Morphologic and immunophenotypic markers as surrogate endpoints of tamoxifen effect for prevention of breast cancer

Medicine and Dentistry

• Analysis 16%
• Arm 16%
• Biological Marker 50%
• Biopsy 16%
• Breast 16%
• Breast Cancer 16%
• Breast Cancer Prevention 16%
• Breast Epithelium 16%
• Breast Tissue 16%
• Diseases 16%
• Follow up 33%
• Hyperplasia 50%
• Incidence 16%
• Indicator 16%
• Mammography 16%
• Marker 16%
• Morphology 16%
• Mortality 16%
• Needle Biopsy 33%
• Observation 16%
• Phenotype 16%
• Tamoxifen 100%
• Tissues 16%
• Woman 66%

Biochemistry, Genetics and Molecular Biology

• Bcl-2 16%
• Clinical Trial 33%
• Incidence 16%
• Morphology 16%
• Mortality 16%
• Phenotype 16%
• Reduction (Chemistry) 16%
• Sample 16%
• Staining 16%
• Time 16%